Answers are grounded in this paper and cite their sources.
The progesterone (P) antagonist RU486 (RU) both lowers and raises P secretion by an apparently direct action on the corpus luteum. P receptors, however, exist in more than one form, and under certain conditions of P's target tissues, RU can act as a P agonist when bound to one of them. RU's paradoxical effects, therefore, may support the theory that P stimulates its own secretion since the conditions under which RU raises P secretion are always different from those in which it lowers it. These effects, however, occur in at least one species, the rat, in which luteal P receptors cannot be found, and there are several excellent reasons to think that the autocrine action of P in no way resembles its action in its target tissues. The system through which P controls its own secretion in all mammals, in other words, is still undiscovered.
No takes yet. Share an insight, caveat, or question.
I. ROTHCHILD (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: